L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria.

MLA

Faverzani, Jéssica Lamberty, et al. “L-Carnitine Protects DNA Oxidative Damage Induced by Phenylalanine and Its Keto Acid Derivatives in Neural Cells: A Possible Pathomechanism and Adjuvant Therapy for Brain Injury in Phenylketonuria.” Metabolic Brain Disease, vol. 36, no. 7, Oct. 2021, pp. 1957–68. EBSCOhost, https://doi.org/10.1007/s11011-021-00780-x.

APA

Faverzani, J. L., Steinmetz, A., Deon, M., Marchetti, D. P., Guerreiro, G., Sitta, A., de Moura Coelho, D., Lopes, F. F., Nascimento, L. V. M., Steffens, L., Henn, J. G., Ferro, M. B., Brito, V. B., Wajner, M., Moura, D. J., & Vargas, C. R. (2021). L-carnitine protects DNA oxidative damage induced by phenylalanine and its keto acid derivatives in neural cells: a possible pathomechanism and adjuvant therapy for brain injury in phenylketonuria. Metabolic Brain Disease, 36(7), 1957–1968. https://doi.org/10.1007/s11011-021-00780-x

Chicago

Faverzani, Jéssica Lamberty, Aline Steinmetz, Marion Deon, Desirèe Padilha Marchetti, Gilian Guerreiro, Angela Sitta, Daniella de Moura Coelho, et al. 2021. “L-Carnitine Protects DNA Oxidative Damage Induced by Phenylalanine and Its Keto Acid Derivatives in Neural Cells: A Possible Pathomechanism and Adjuvant Therapy for Brain Injury in Phenylketonuria.” Metabolic Brain Disease 36 (7): 1957–68. doi:10.1007/s11011-021-00780-x.